Vivos TherapeuticsVVOS
13F holders, Q2 2024 (June 30)19holders +3
5new positions
2sold out
$2.32avg. 13F price*
At the end of Q2 2024, 19 institutions reported holding Vivos Therapeutics Inc. (VVOS) in their 13F filings, up 3 from Q1 2024. 5 opened new positions and 2 sold out. The largest holders were Strategic Wealth Investment Group, LLC ($304K), Geode Capital Management, LLC ($46K) and Commonwealth Equity Services, LLC ($36K).
- Company
- Vivos Therapeutics Inc.
- CUSIP
- 92859E207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $54K |
| Exits | 2 | $500K |
All 13F filers, Q1 2024 → Q2 2024: 25,997 shares bought and 104,264 shares sold, net −78,267 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 19 holders
| Strategic Wealth Investment Group, LLC | 0.04% | — | 128,789 | $304K |
| Geode Capital Management, LLC | 0.00% | New | 20,691 | $46K |
| Commonwealth Equity Services, LLC | 0.00% | Add +6.7% | 16,000 | $36K |
| Vanguard Group Inc. | 0.00% | No change | 10,579 | $23K |
| Triad Wealth Partners, LLC | 0.00% | New | 2,818 | $6K |
| Credit Agricole S A | 0.00% | No change | 2,365 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +32.0% | 2,283 | $5K |
| NFSG Corp | 0.00% | Reduce -34.6% | 1,275 | $3K |
| Osaic Holdings, Inc. | 0.00% | New | 898 | $2K |
| Signaturefd, LLC | 0.00% | No change | 547 | $1K |
| Blue Trust, Inc. | 0.00% | No change | 160 | $773 |
| Group One Trading LLC | 0.00% | No change | 228 | $506 |
| Bank of America Corp. | 0.00% | Add +28.8% | 103 | $229 |
| Morgan Stanley | 0.00% | Add +1.5% | 68 | $151 |
| Kozak & Associates, Inc. | 0.00% | No change | 49 | $118 |
| Global Retirement Partners, LLC | 0.00% | No change | 23 | $51 |
| TD Waterhouse Canada Inc. | 0.00% | New | 12 | $28 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 8 | $18 |
| Royal Bank of Canada | 0.00% | No change | 7 | $0 |
"% of holder's portfolio" is VVOS's weight in each manager's 13F, not the share of Vivos Therapeutics Inc. the manager owns.